Medicines and Healthcare Products Regulatory Agency
Asiantaeth weithredol, a elwir hefyd yn MHRA
Cais 944
Data for effectiveness of Covid-19 Innova rapid test used in health-/care settings
Cais am adolygiad mewnol a anfonwyd at Medicines and Healthcare Products Regulatory Agency gan Mia Cartwright ar .
Yn aros am adolygiad mewnol.
Dear MHRA Customer Services,
Re FOI 22/1219
Thank you for your reply to my request.
Thank you also for clarifying the status of the Innova 25 devi...
Safety signal and related safety event reporting for UK CV19 vaccine products
Ymateb gan Medicines and Healthcare Products Regulatory Agency i Mr B Kingsley ar .
Yn aros am gael ei ddosbarthu.
FOI 23/162
Dear Mr B Kingsley,
Thank you for your email and we apologise for delay in response.
Please find attached the response to your FOI reques...
Fluenz Tetra nasal spray suspension Influenza vaccine (live attenuated, nasal)
Ymateb gan Medicines and Healthcare Products Regulatory Agency i Malcolm Day ar .
Yn aros am gael ei ddosbarthu.
FOI 23/326
Dear Malcolm Day,
Thank you for your email of 1st May where you have asked "please provide the following information for the Fluenz Tetra...
Rybelsus Parallel Import (PLPI) Licences
Ymateb gan Medicines and Healthcare Products Regulatory Agency i Tom Henderson Silva ar .
Llwyddiannus.
Dear Tom,
Thank you for your enquiry to the MHRA.
There are no UK parallel import licences (PLPIs) that have been granted for Rybelsus according to o...
ICH guideline S1B(R1) on testing for carcinogenicity of pharmaceuticals
Ymateb gan Medicines and Healthcare Products Regulatory Agency i Alice Sav ar .
Yn aros am ymateb.
Our Ref: FOI 23/383
Dear Alice Sav,
RE: REQUEST UNDER THE FREEDOM OF INFORMATION ACT 2000
Thank you for your enquiry which we received on 25th May....
Updated Yellow card data for the Isle of Man on Covid-19 vaccines
Ymateb gan Medicines and Healthcare Products Regulatory Agency i Natalie Birchall ar .
Yn aros am gael ei ddosbarthu.
Our Ref: FOI 23/381
Dear Natalie Birchall
RE: REQUEST UNDER THE FREEDOM OF INFORMATION ACT 2000
Thank you for your enquiry which we will commence re...
MHRA Internal communications relating to FOIA Request 23/105
Cais i Medicines and Healthcare Products Regulatory Agency gan CHP Gillow. Wedi ei anodi gan CHP Gillow ar .
Hwyr.
Complaint submitted to ICO
Internal Communication in respect of FOIA request 23/073
Cais i Medicines and Healthcare Products Regulatory Agency gan CHP Gillow. Wedi ei anodi gan CHP Gillow ar .
Hwyr.
Complaint submitted to ICO
Lipid-related impurity issues for BNT162b2
Dilynol a anfonwyd at Medicines and Healthcare Products Regulatory Agency gan Jonathan Weissman ar .
Yn aros am ymateb.
Dear MHRA Customer Services,
Given the ICO's decision notice dated 6 March 2023 [1] compels the MHRA to respond to all 5 of my FOI requests previousl...
Section 3.2.P.1 for all approved COVID-19 vaccines
Dilynol a anfonwyd at Medicines and Healthcare Products Regulatory Agency gan Jonathan Weissman ar .
Yn hwyr iawn
Dear MHRA Customer Services,
Over two months have now passed since I raised this request. Your response to this request is long overdue. Please provi...
Contamination, exact ingredients and WFI GMP for Pfizer's product BNT162b2
Ymateb gan Medicines and Healthcare Products Regulatory Agency i Jonathan Weissman ar .
Rhannol lwyddiannus.
Internal Review of FOI 22/387
Dear Mr Jonathan Weissman
Thank you for your email.
Please find attached the reply to your Internal Rev...
Important protocol deviations within 7 days after Dose 2 in BNT162b2 clinical trial
Ymateb gan Medicines and Healthcare Products Regulatory Agency i Jonathan Weissman ar .
Rhannol lwyddiannus.
FOI 23/211
Dear Mr Weissman,
Thank you for your information request dated 19 February 2022 where you
asked for information related COVID-1...
NaOH and HCl Excipients in Pfizer’s SmPC for Comirnaty
Ymateb gan Medicines and Healthcare Products Regulatory Agency i Jonathan Weissman ar .
Rhannol lwyddiannus.
FOI 23/325
Dear Mr Weissman,
Thank you for your request under the Freedom of Information Act, we
apologise for the delay in response.
...
Wholesale Inpection Defficiencies
Ymateb gan Medicines and Healthcare Products Regulatory Agency i Michael Devlin ar .
Yn aros am gael ei ddosbarthu.
Mr Devlin
Apologies for the delay.
Reg 43 (5) of the 2012 Human Medicines Regulations provides a WDA holder mut not sell supply or offer a medicine un...
Pfizer BNT162b2 conditions of authorisation
Ymateb gan Medicines and Healthcare Products Regulatory Agency i Alex Hicks ar .
Yn aros am gael ei ddosbarthu.
Our ref: FOI: 23/150
Dear Alex Hicks,
Thank you for your request under the Freedom of Information Act, we apologise for the delay in response.
We ha...
FOIA request - MHRA Managing Medical Devices - Guidance for health and social care organisations - January 2021
Ymateb gan Medicines and Healthcare Products Regulatory Agency i Marc Jordan ar .
Yn hwyr iawn
Internal Review of FOI 23/218
Dear Marc Jordan,
Thank you for your email.
We confirm that an internal review will be carried out on FOI 23/218. We n...
Disclosure Log - List of FOIA requests answered fully or in part since 1 January 2021 including requests where the MHRA holds no information
Dilynol a anfonwyd at Medicines and Healthcare Products Regulatory Agency gan CHP Gillow ar .
Yn aros am gael ei ddosbarthu.
Dear MHRA Customer Services,
To clarify the position:
This request was submitted on 18 January 2023. I was asking you to make available the disc...
Inventory of items submitted in support of Vaxzevria's Temporary and Conditional Marketing Authorisations
Ymateb gan Medicines and Healthcare Products Regulatory Agency i CHP Gillow ar .
Yn aros am gael ei ddosbarthu.
Our ref: FOI 23/073
Dear Mr Gillow,
Thank you for your request of 27 January 2023, we apologise for the long
delay in reply.
We have...
Nucleotide base sequence for "davesomeran"
Ymateb gan Medicines and Healthcare Products Regulatory Agency i Matt Cooper ar .
Yn aros am gael ei ddosbarthu.
Dear Mr Cooper,
Please find attached, the final response to the above-referenced Freedom
of Information request.
Kind regards,
...
Recent evidence on vape regulatory enforcement in the UK
Ymateb gan Medicines and Healthcare Products Regulatory Agency i Jordan Millar ar .
Yn aros am gael ei ddosbarthu.
Dear Jordan Millar,
Thank you for your email.
We acknowledge that the request is outstanding and we apologise for the delay.
Kind Regards
MHRA Cust...
COVID-19 vaccine data
Ymateb gan Medicines and Healthcare Products Regulatory Agency i DAVID ar .
Yn aros am ymateb.
Our Ref: FOI 23/358
Dear Mr D Tait,
RE: REQUEST UNDER THE FREEDOM OF INFORMATION ACT 2000
Thank you for your enquiry which we received on 19th May....
Specification for dsDNA concentration in mRNA COVID-19 vaccine products
Ymateb gan Medicines and Healthcare Products Regulatory Agency i Matt Cooper ar .
Yn aros am gael ei ddosbarthu.
FOI 23/236
Dear Matt Cooper,
Thank you for your email of 29th March where you have asked " Please
release the specification and/or tolerance f...
IBI Corr
Ymateb gan Medicines and Healthcare Products Regulatory Agency i JJ Evans ar .
Yn hwyr iawn
Our Ref: FOI 23/181
Dear JJ Evans,
RE: REQUEST UNDER THE FREEDOM OF INFORMATION ACT 2000
Thank you for your enquiry which we received on 10 March 20...
Requesting Data from any completed Clinical Trial for my MSc Data Science Dissertation project and research
Gwrthodwyd.
FOI 23/209
Dear Ankur Sangani,
Thank you for your email.
We do not receive these so we cannot provide the data and we advise that you contact the tr...
Data on pregnant women who took the covid injections
Ymateb gan Medicines and Healthcare Products Regulatory Agency i N Davies ar .
Hwyr.
Internal Review of FOI 23/276
Dear N Davies,
Thank you for your email.
We confirm that an internal review will be carried out on FOI...
Dim ond ceisiadau a wnaed gan ddefnyddio WhatDoTheyKnow a ddangosir. ?